Apollo Hospitals reports over 35% drop in Q1 net profit to ₹317 crore

Consolidated revenue from operations stood at 3,795.60 in crores Q1FY23 slightly above 3,760.21 crore in Q1 last year. But revenue climbed more than 7% 3,546.43 crore in Q4FY22.

In Q1FY23, the total income of the company was 3,811.66 crore as compared to 3,784.85 crore in the same period a year ago.

On segment-wise performance, the company’s health care Services business recorded revenue Q1FY23 vs . 2,032.07 crore in 1,941.24 crore in Q1FY22. In addition, it earned a revenue of 6.26 crores in 24X7 digital business during the first quarter of the current financial year.

In addition, the company’s clinic business saw a revenue of Q1FY23 vs . 293.01 crore in 309 crore in Q1FY22. Meanwhile, the pharmacy distribution segment saw a revenue of 1,472.92 crore in Q1FY23 as against 1,512 crore in Q1 of FY22. Other business revenue at . came in 1.16 crore as compared to 1.06 crore in Q1FY22.

Meanwhile, Apollo Hospitals’ overall expenses soared 3,545.36 crore in Q1FY23 as against 3,475.58 crore in the same quarter of FY22.

Shares of the company closed on BSE below 4,434.25 84.80 or 1.88%. Shares have touched intraday highs and lows 4,555 each and 4,415.30 each respectively.

The market cap of the company is approx. 63,757.71 crore.

Established in 1983, from routine health and preventive health care to innovative life-saving treatments and diagnostic services, Apollo Hospitals has touched the lives of over 120 million people in over 120 countries, providing the best clinical outcomes. offer. Apollo Hospitals has been a pioneer in bringing unprecedented healthcare technology to India.

In India, Apollo’s presence includes over 10,000 beds in 73 hospitals, over 4,500 pharmacies, over 300 clinics, 1100 diagnostic centers and 200 telemedicine units in 17 countries.

first article